# Sionna Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Apr 20, 2026

- Company: [Sionna Therapeutics, Inc.](/companies/sion.md) (CIK 2036042)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-20
- Accepted by EDGAR: Apr 20, 2026, 18:46 ET
- Period: not reported
- Accession: 0000947871-26-000456
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2036042/000094787126000456/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2036042/000094787126000456/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2036042/000094787126000456/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 20, 2026.
Source: SEC EDGAR, the filing index for accession 0000947871-26-000456. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.
